Position in RPRX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$28,925
+$5,626 QoQ
Shares Held
603
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Smithfield Trust Co holds $563,573 across 10 Biotechnology names. RPRX ranks #4 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
332 | $256,516 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
503 | $224,609 | |
| 3 | INCY |
Incyte Corp
|
323 | $30,400 | |
| 4 | RPRX |
Royalty Pharma plc
This page
|
603 | $28,925 | |
| 5 | CYTK |
Cytokinetics Inc
|
155 | $10,216 | |
| 6 | TECH |
BIO-TECHNE Corp
|
148 | $7,734 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
606 | $2,393 | |
| 8 | ARGX |
Argenx SE
|
2 | $1,460 |
All Filings in RPRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,925 | 603 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $23,299 | 603 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $21,520 | 610 | Shares | Sole | 2025-11-07 | |
| No filing history on record for this holder in this stock. | ||||||